They concluded that even if prostate carcinomas were considered normally negative for KRT7, some tumors may exhibit KRT7 reactivity, ranging from a few scattered positive cells via positive tumor areas to homogeneously positive tumors [19]. This evidence concerns the gene KRT7 and prostate carcinoma.